Shares of Colgate-Palmolive (NYSE:CL – Get Free Report) have been assigned a consensus rating of “Hold” from the twenty brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $102.12.
CL has been the subject of several research analyst reports. Stifel Nicolaus lowered their price objective on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Barclays lowered their price objective on Colgate-Palmolive from $89.00 to $86.00 and set an “equal weight” rating for the company in a report on Friday, April 11th. Wells Fargo & Company boosted their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the company an “underweight” rating in a report on Wednesday, April 2nd. Piper Sandler lowered their price objective on Colgate-Palmolive from $108.00 to $107.00 and set an “overweight” rating for the company in a report on Monday, March 31st. Finally, Wall Street Zen lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th.
Check Out Our Latest Research Report on CL
Hedge Funds Weigh In On Colgate-Palmolive
Colgate-Palmolive Stock Up 1.9%
Shares of NYSE CL opened at $92.67 on Friday. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The firm has a market cap of $75.10 billion, a price-to-earnings ratio of 26.33, a PEG ratio of 4.20 and a beta of 0.39. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92. The stock’s 50-day simple moving average is $91.81 and its 200-day simple moving average is $91.24.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same period in the previous year, the company earned $0.86 earnings per share. The company’s revenue for the quarter was down 3.0% compared to the same quarter last year. As a group, equities analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th were given a dividend of $0.52 per share. The ex-dividend date was Thursday, April 17th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a dividend yield of 2.24%. Colgate-Palmolive’s payout ratio is currently 58.76%.
Colgate-Palmolive declared that its Board of Directors has initiated a stock buyback program on Thursday, March 20th that allows the company to buyback $5.00 billion in shares. This buyback authorization allows the company to repurchase up to 6.8% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Why Invest in 5G? How to Invest in 5G Stocks
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- Expert Stock Trading Psychology Tips
- 3 Trades Members of Congress Are Making Right Now
- Where Do I Find 52-Week Highs and Lows?
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.